CN108484548A - A kind of preparation method of 5- nitro-benzofurans -2- formic ether compounds - Google Patents

A kind of preparation method of 5- nitro-benzofurans -2- formic ether compounds Download PDF

Info

Publication number
CN108484548A
CN108484548A CN201810506887.XA CN201810506887A CN108484548A CN 108484548 A CN108484548 A CN 108484548A CN 201810506887 A CN201810506887 A CN 201810506887A CN 108484548 A CN108484548 A CN 108484548A
Authority
CN
China
Prior art keywords
preparation methods
formula
preparation
compound
dibromoethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810506887.XA
Other languages
Chinese (zh)
Inventor
束影
周培
傅扣婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yangzhou Polytechnic Institute
Original Assignee
Yangzhou Polytechnic Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yangzhou Polytechnic Institute filed Critical Yangzhou Polytechnic Institute
Priority to CN201810506887.XA priority Critical patent/CN108484548A/en
Publication of CN108484548A publication Critical patent/CN108484548A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of preparation methods of 5 nitrobenzofuran, 2 formic ether compounds, specifically comprise the following steps:

Description

A kind of preparation method of 5- nitro-benzofurans -2- formic ether compounds
Technical field
The invention belongs to pharmaceutical synthesis fields, and in particular to a kind of 5- nitro-benzofurans -2- formic ether compounds Preparation method.
Background technology
Vilazodone (Vilazodone), the trade name Viibryd of hydrochloride are a kind of choosings with double action Selecting property serotonin reuptake inhibitor and 5-HTIA acceptor portion agonists are clinically mainly used for treating major depression's disease, U.S. Food and Drug Administration (FDA) approval Vilazodone Hydrochloride piece is for treating severe depression in adult at the beginning of 2011 Disease.Key intermediate 5- substitutions--2 formate ester intermediate of benzofuran is all be unable to do without in the synthetic method reported at present.This A kind of one-step method of invention offer prepares the preparation method of -2 formate ester intermediate of 5- nitro-benzofurans.
Invention content
The present invention provides a kind of preparation method of -2 formic ether compounds of 5- nitro-benzofurans of Formula II structure, It is characterized in that including the following steps:
Compound of formula I in organic solvent, reacts production II compounds with sym-dibromoethylene under alkaline reagent effect;
R is selected from the alkyl optionally replaced, the C1-C6 alkyl preferably optionally replaced by halogen, phenyl, further preferred Me, Et、Bn。
Compound of formula I and the molar ratio of sym-dibromoethylene are 1:1.0-1.5 preferably 1:1.0-1.2;Reaction temperature preferably- 40 DEG C at room temperature;Reaction time is 8-12 hours preferred;The preferred THF of organic solvent, dioxane etc.;Alkaline reagent is selected from The mole dosage of one or more of LiHMDS, NaHMDS, BuLi, t-BuLi, alkaline reagent are compound of formula I mole 1.5-2.0 again.
Another embodiment of the present invention provides the above-mentioned method for preparing -2 formic ether compounds of 5- nitro-benzofurans Application in preparing vilazodone.
Compared with the prior art, the advantages of the present invention are as follows:The present invention using Bromofume alkaline reagent effect under with Compound of formula I single step reaction prepares 5- nitro-benzofuran -2- formic ether compounds, is provided newly for the synthesis of vilazodone Method and technology path.
Specific implementation mode
For the ease of a further understanding of the present invention, examples provided below has done more detailed description to it.But It is that these embodiments are only not supposed to be a limitation to the present invention or implementation principle for being better understood from invention, reality of the invention The mode of applying is not limited to the following contents.
Embodiment 1
Compound 1 (1.0mmol) and sym-dibromoethylene (1.0mmol) are dissolved in THF, at -40 DEG C, LiHMDS is added (2.0mmol) keeps -40 DEG C of reactions 12 hours (TLC detection compounds 1 completely disappear), saturated ammonium chloride is added, reaction is quenched, After removing THF under reduced pressure, ethyl acetate extraction is added, is washed successively with saturated sodium bicarbonate, saturated sodium-chloride, merges organic phase Afterwards, with anhydrous sodium sulfate drying, filtering, after filtrate concentration, chemical combination is obtained through silica gel column chromatography (ethyl acetate/petroleum ether=1/20) Object 2 (201mg, yield 85.5%, HPLC purity are 97.3%,1H NMR are consistent with known report).
Embodiment 2
Compound 3 (1.0mmol) and sym-dibromoethylene (1.2mmol) are dissolved in THF, under ice salt bath, BuLi is added (1.5mmol) keeps ice salt bath reaction 8 hours (TLC detection compounds 3 completely disappear), saturated ammonium chloride is added, reaction is quenched, After removing THF under reduced pressure, ethyl acetate extraction is added, is washed successively with saturated sodium bicarbonate, saturated sodium-chloride, merges organic phase Afterwards, with anhydrous sodium sulfate drying, filtering, after filtrate concentration, chemical combination is obtained through silica gel column chromatography (ethyl acetate/petroleum ether=1/20) Object 4 (184mg, yield 83.2%, HPLC purity are 96.5%,1H NMR are consistent with known report).
Embodiment 3
Compound 5 (1.0mmol) and sym-dibromoethylene (1.5mmol) are dissolved in THF, at -20 DEG C, NaHMDS is added (1.8mmol) keeps -20 DEG C of reactions 10 hours (TLC detection compounds 5 completely disappear), saturated ammonium chloride is added, reaction is quenched, After removing THF under reduced pressure, ethyl acetate extraction is added, is washed successively with saturated sodium bicarbonate, saturated sodium-chloride, merges organic phase Afterwards, with anhydrous sodium sulfate drying, filtering, after filtrate concentration, chemical combination is obtained through silica gel column chromatography (ethyl acetate/petroleum ether=1/25) (96.8%) 120mg, yield 40.4%, HPLC purity are to object 6.1H-NMR(600MHz,CDCl3):δ 8.06 (d, J=1.9, 1H), 7.85-7.77 (m, 4H), 7.44-7.35 (m, 4H), 5.39 (s, 2H).

Claims (10)

1. a kind of preparation method of -2 formic ether compounds of 5- nitro-benzofurans of Formula II structure, it is characterised in that including Following steps:
Compound of formula I in organic solvent, reacts production II compounds with sym-dibromoethylene under alkaline reagent effect;Wherein R Selected from the alkyl optionally replaced.
2. preparation method described in claim 1, it is characterised in that the alkaline reagent is selected from LiHMDS, NaHMDS, BuLi, t- One or more of BuLi.
3. claim 1-2 any one of them preparation methods, it is characterised in that compound of formula I and the molar ratio of sym-dibromoethylene are 1:1.0-1.5;The mole dosage of alkaline reagent is 1.5-2.0 times of compound of formula I mole.
4. claim 1-3 any one of them preparation methods, it is characterised in that compound of formula I and the molar ratio of sym-dibromoethylene are 1:1.0-1.2。
5. claim 1-4 any one of them preparation methods, it is characterised in that reaction temperature is preferably at -40 DEG C at room temperature.
6. claim 1-5 any one of them preparation methods, it is characterised in that the reaction time is 8-12 hours preferred.
7. claim 1-6 any one of them preparation methods, it is characterised in that the preferred THF of organic solvent, dioxane etc..
8. claim 1-7 any one of them preparation methods, it is characterised in that R is selected from the C1- optionally replaced by halogen, phenyl C6 alkyl.
9. claim 1-8 any one of them preparation methods, it is characterised in that R is selected from Me, Et, Bn.
10. application of the claim 1-9 any one of them preparation methods in preparing vilazodone.
CN201810506887.XA 2018-05-23 2018-05-23 A kind of preparation method of 5- nitro-benzofurans -2- formic ether compounds Pending CN108484548A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810506887.XA CN108484548A (en) 2018-05-23 2018-05-23 A kind of preparation method of 5- nitro-benzofurans -2- formic ether compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810506887.XA CN108484548A (en) 2018-05-23 2018-05-23 A kind of preparation method of 5- nitro-benzofurans -2- formic ether compounds

Publications (1)

Publication Number Publication Date
CN108484548A true CN108484548A (en) 2018-09-04

Family

ID=63351693

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810506887.XA Pending CN108484548A (en) 2018-05-23 2018-05-23 A kind of preparation method of 5- nitro-benzofurans -2- formic ether compounds

Country Status (1)

Country Link
CN (1) CN108484548A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473786B1 (en) * 2003-12-05 2009-01-06 University Of Massachusetts Methods and systems for preparing fused heterocyclic compounds using copper(I) catalysts
CN102108070A (en) * 2011-01-26 2011-06-29 上海优贝德生物医药有限公司 Preparation methods of 5-aminobenzofuran-2-formate and intermediate thereof
CN103304527A (en) * 2012-03-16 2013-09-18 无锡万全医药技术有限公司 Novel preparation method of 5-nitrobenzofuran-2-formic acid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473786B1 (en) * 2003-12-05 2009-01-06 University Of Massachusetts Methods and systems for preparing fused heterocyclic compounds using copper(I) catalysts
CN102108070A (en) * 2011-01-26 2011-06-29 上海优贝德生物医药有限公司 Preparation methods of 5-aminobenzofuran-2-formate and intermediate thereof
CN103304527A (en) * 2012-03-16 2013-09-18 无锡万全医药技术有限公司 Novel preparation method of 5-nitrobenzofuran-2-formic acid

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
VICENTE DEL AMO ET AL.: "General Preparation of Primary, Secondary, and Tertiary Aryl Amines by the Oxidative Coupling of Polyfunctional Aryl and Heteroaryl Amidocuprates", 《ANGEW. CHEM. INT. ED》 *
XIAOHONG CHEN ET AL.: "Practical regioselective halogenation of vinylogous esters: synthesis of differentiated mono-haloresorcinols and polyhalogenated resorcinols", 《TETRAHEDRON》 *

Similar Documents

Publication Publication Date Title
AU2013265119B2 (en) Catechol O-methyltransferase activity inhibiting compounds
CA2495685A1 (en) Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
EP1966127B1 (en) Carbonyl asymmetric alkylation
AU2015281021B2 (en) Salt of halogen-substituted heterocyclic compound
CN111484442A (en) Preparation method of CSF1R inhibitor intermediate with antitumor activity
CN105820174B (en) A kind of preparation method of polysubstituted thiophene diindyl derivative
CN108484548A (en) A kind of preparation method of 5- nitro-benzofurans -2- formic ether compounds
CN107501222A (en) A kind of breviscapine B aglycone derivative and preparation method and application
CN105121419B (en) Cabazitaxel class anti-multidrug resistance taxane antitumor compound and preparation method thereof
CN108558802A (en) A kind of preparation method of 5- halo-benzofurans -2- formic ether compounds
CN101805339B (en) Entecavir compound preparation method
WO2014132940A1 (en) Method for producing α-halo-tetraacyl glucose
JP3937489B2 (en) Method for producing propargylamine compound
JP5009736B2 (en) Mannich reaction using cyclic amino ether
JPS61148173A (en) Novel amine and its salt
CN105712956B (en) A kind of preparation method of gentle efficient polyfunctional group substituted epoxy class compound
CN104926797B (en) Furanone derivatives, Preparation method and use
JP2004532247A (en) Chloromethylation of thiophene
CN103755667B (en) A kind of chirality 3-(2-nitro-ethyl) tetrahydrofuran-compound and preparation method thereof
KR101058530B1 (en) Method for preparing panesyl acetone derivatives for treating hypertension and intermediates thereof
CN108218937A (en) The optical isomer of nucleoside phosphoramidate class compound and its application
TWI811428B (en) Bicyclic Heteroaromatic Derivatives
CN115746071A (en) Diphyllin glucoside derivative or pharmaceutically acceptable derivative or analogue thereof, and preparation method and application thereof
JP2008088115A (en) Process for preparing substituted amino acid schiff base compound
CN105541695B (en) A kind of 2 aryl fluorides are for piperidine derivative and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180904